Citi Downgrades Medivation (MDVN) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. ZETA

Go back to Citi Downgrades Medivation (MDVN) to Neutral

Pfizer To Acquire Medivation

August 22, 2016 6:45 AM EDT

Propels Pfizer into a leading position in oncology Medivation agrees to transaction valued at $81.50 per Medivation share in cash, for a total enterprise value of approximately $14 billion Expected to be immediately accretive to Pfizers Adjusted Diluted EPS upon closing, approximately $0.05 accretive in first full year after close with additional accretion and growth anticipated thereafter

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today... More